In a clinical trial, the highest dose of orforglipron led to 11.2 percent weight loss at 72 weeks
Analyzing the historical market, estimating the current market, and forecasting the future market of the global GLP-1 Analogues market were the three major steps undertaken to create and analyze the adoption of GLP-1 Analogues in major regions globally
With retatrutide and other multi-agonists on the horizon, we may soon see drugs that approach the effectiveness of bariatric surgery without the invasiveness
While it is an investment, its versatility makes it a powerful tool for overall facial rejuvenation
If you have plateaued on current medications, have fatty liver disease, or simply want to understand what is coming next, retatrutide is the most promising drug in the pipeline
Helps Patients Choosing the right GLP-1 treatment can feel confusing